The DOI matches its Crossref record; 110 of the 111 references it cites were found in a registry or an index; none of the 159 sources its claims cite is checked for support yet.
Amyloid β production along the neuronal secretory pathway: Dangerous liaisons in the Golgi?
Open accessAbstract
β‐amyloid peptides (Aβ) are generated in intracellular compartments of neurons and secreted to form cytotoxic fibrils and plaques. Dysfunctional membrane trafficking contributes to aberrant Aβ production and Alzheimer's disease. Endosomes represent one of the major sites for Aβ production and recently the Golgi has re‐emerged also as a major location for amyloid precursor protein (APP) processing and Aβ production. Based on recent findings, here we propose that APP processing in the Golgi is finely tuned by segregating newly‐synthesised APP and the β‐secretase BACE1 within the Golgi and into distinct trans‐Golgi network transport pathways. We hypothesise that there are multiple mechanisms responsible for segregating APP and BACE1 during transit through the Golgi, and that perturbation in Golgi morphology associated with Alzheimer's disease, and or changes in cholesterol metabolism associated with Alzheimer's disease risk factors, may lead to a loss of partitioning and enhanced Aβ production.
Overview
CoChat Summary
TL;DR
This commentary hypothesizes that APP and BACE1 are segregated into distinct Golgi/TGN transport pathways, and that perturbations in Golgi morphology, lipid/cholesterol metabolism, or sorting motifs cause loss of partitioning and enhanced Aβ production. It proposes a positive feedback loop in which Aβ drives Golgi fragmentation and altered membrane microdomains, further increasing amyloidogenic APP processing in Alzheimer’s disease.
Key findings
- The TGN is proposed as the earliest compatible secretory-pathway site for substantial BACE1 cleavage of APP, because BACE1 is activated in the late Golgi and has optimal activity in acidic compartments; retention of endogenous BACE1 or APP in the TGN in primary mouse neurons increases APP cleavage and production/secretion of both Aβ40 and Aβ42.
- APP and BACE1 exit the TGN by independent pathways: BACE1 export is regulated by its DDISLL motif and AP-1/ARF1/ARF4, whereas APP trafficking is regulated by a YKFFEE sequence recognized by AP-4/Arl5b; overexpressed BACE1 and APP were detected in different transport carriers in primary neurons after TGN exit.
- Golgi fragmentation is associated with increased APP processing and Aβ production, and restoration of a compact Golgi in animal models of AD protects from disease progression; Aβ promotes Golgi fragmentation via cdk5 phosphorylation of GRASP65.
- Cholesterol and APOE4 are proposed to disrupt TGN membrane organization and sorting: APOE4, the strongest genetic risk factor for LOAD, raises circulating cholesterol and enhances amyloid pathology, and cholesterol influences membrane properties and protein sorting in secretory and endocytic pathways.
Methods
- Design: commentary/hypothesis article, not a primary experimental study; it synthesizes published findings and proposes a model with schematic figures.
- Data or sample: no new sample; it cites prior studies using neuronal and non-neuronal cells, primary mouse neurons, HeLa, HEK, COS cells, transgenic mice, and human iPSC-derived neurons.
- Main analysis: conceptual synthesis and model building, including proposed mechanisms of APP/BACE1 partitioning, Golgi fragmentation, lipid-mediated sorting, and outstanding questions.
Limitations
- Stated by the paper: outstanding questions include the contribution of local secretory pathways in dendrites and axons to APP processing/Aβ production; the impact of Golgi fragmentation on TGN subdomain organization, membrane lipids, and cargo exit; consequences for Golgi exit kinetics; effects on ER-contact sites and lipid homeostasis; inflammasome activation; and whether restoring a compact Golgi reduces APP processing and Aβ production. The paper also notes that studies analyzing APP location in neurons are limited, there are conflicting reports on γ-secretase detection in the neuronal TGN, and the molecular basis for enhanced APP processing of most familial APP mutations is unknown.
- Evident from the text: the central model is a hypothesis and is not directly tested here; it relies on cited studies, some using overexpressed proteins or non-neuronal cell systems.
- Evident from the text: the proposed positive feedback loop between Aβ, Golgi fragmentation, and altered membrane microdomains is not experimentally resolved in this commentary.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 9 Not valid · 97 Not checked · 49 Own results and interpretations
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“recently the Golgi has re-emerged also as a major location for amyloid precursor protein (APP) processing and Aβ production.”
- Also stated in: § Introduction: Role of amyloid peptides in the aetiology of Alzheimer's disease · plain
“Recent studies have also highlighted a role for the secretory pathway and the Golgi apparatus as a major location for APP processing and Aβ production and secretion [23][24][25][26] .”
§ Amyloid β production along the neuronal secretory pathway: Dangerous liaisons in the Golgi? > Abstract
What the sources say
- Not matchedcites [23]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction: Role of amyloid peptides in the aetiology of Alzheimer's disease · plain
In the paper
“The Golgi undergoes changes in morphology in Alzheimer's disease which are likely to contribute to disease pathology.”
- Also stated in: § Introduction: Role of amyloid peptides in the aetiology of Alzheimer's disease · hedged
“Golgi morphology is altered in AD, and perturbation in Golgi architecture is likely to impact on APP processing 29 .”
§ Amyloid β production along the neuronal secretory pathway: Dangerous liaisons in the Golgi? > Abstract
What the sources say
- Not matchedcites [29]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction: Role of amyloid peptides in the aetiology of Alzheimer's disease · hedged
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“For example, some of the LOAD risk factors, such as sortilin related receptor and VPS35 are integral components of the retromer-mediated transport to the TGN 14,15 .”
§ Amyloid β production along the neuronal secretory pathway: Dangerous liaisons in the Golgi? > Introduction: Role of amyloid peptides in the aetiology of Alzheimer's disease
What the sources say
- Not matchedcites [14]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [15]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Endosomes represent one of the major sites for Aβ production and recently the Golgi has re-emerged also as a major location for amyloid precursor protein (APP) processing and Aβ production.”
§ Amyloid β production along the neuronal secretory pathway: Dangerous liaisons in the Golgi? > Abstract
What the sources say
- Not matchedcites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [11]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“the trans-Golgi network (TGN) and early/late endosomes are compatible locations 13 .”
§ Amyloid β production along the neuronal secretory pathway: Dangerous liaisons in the Golgi? > Introduction: Role of amyloid peptides in the aetiology of Alzheimer's disease
What the sources say
- Not matchedcites [13]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
82 more claims
Create a free account to see all 155 claims and every source verdict.
- Probably not a substantial claim. 32
- It may state two separate claims as one. 47
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167
Linking lipids to Alzheimer's disease: cholesterol and beyond
Di Paolo, G., & Kim, T.-W. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3012 · Cited by 972
Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505082 · Cited by 967
Microglia in Alzheimer's disease
Sarlus, H., & Heneka, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90606 · Cited by 911
Mechanisms governing autophagosome biogenesis
Nakatogawa, H. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0241-0 · Cited by 879
PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation
Chen, J., & Chen, Z. J. (2018) · Nature · doi:10.1038/s41586-018-0761-3 · Cited by 692
Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer
Seaman, M. N. J. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312034 · Cited by 624
Cited by
Rudajev, V., & Novotný, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01127-y · Cited by 54
Therapeutic Targeting of Rab GTPases: Relevance for Alzheimer’s Disease
Jordan, K. L., Koss, D. J., Outeiro, T. F., & Giorgini, F. (2022) · Biomedicines · doi:10.3390/biomedicines10051141 · Cited by 33
Saeed, M. M., Fernández‐Ochoa, Á., Saber, F. R., Sayed, R. H., Cádiz‐Gurrea, M. D. L. L., Elmotayam, A. K., Leyva‐Jiménez, F. J., Segura‐Carretero, A., & Nadeem, R. I. (2022) · Molecules · doi:10.3390/molecules27207118 · Cited by 29
Aging impact on amyloid precursor protein neuronal trafficking
Burrinha, T., & Guimas Almeida, C. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102524 · Cited by 26
Choi, W., Kang, S., & Kim, J. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01408-z · Cited by 26
Wang, J., Gleeson, P. A., & Fourriere, L. (2024) · Traffic · doi:10.1111/tra.12932 · Cited by 18
Self-citationFourriere, L., Cho, E. H., & Gleeson, P. A. (2022) · Traffic · doi:10.1111/tra.12831 · Cited by 16
Self-citationMechanistic insights into cargo sorting and export from the Golgi apparatus
Watson, E. T., Wegeng, W. R., Aravani, S., Ernst, A. M., & von Blume, J. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00907-3 · Cited by 15
Monsalvo-Maraver, L. Á., Maya-López, M., Rangel‐López, E., Túnez, I., Tinkov, A. A., Skalny, A. V., Ferrer, B., Aschner, M., & Santamaría, A. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220616094036 · Cited by 14
Cassano, T., Giamogante, F., Calcagnini, S., Romano, A., Lavecchia, A. M., Inglese, F., Paglia, G., Bukke, V. N., Romano, A. D., Friuli, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033005 · Cited by 14
Rosales‐Hernández, M. C., Valdez, M. O., Toledano, J. V., Wejebe, J. E. M., Morales, L. G. F., & Cruz, A. (2024) · Molecules · doi:10.3390/molecules29194780 · Cited by 13
Malik, N., Miah, M.-U., Galgani, A., McAleese, K. E., Walker, L., LeBeau, F. E. N., Attems, J., Outeiro, T. F., Thomas, A. J., & Koss, D. J. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02691-4 · Cited by 6
Fourrière, L., & Gleeson, P. A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1550211 · Cited by 6
Self-citationA Question of Origins: Non-neuronal Sources of Amyloid-β
Sasmita, A. O., & Depp, C. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-025-01572-4 · Cited by 5
Jadhav, D., Knapinska, A. M., Wang, H., & Fields, G. B. (2025) · Biomolecules · doi:10.3390/biom15081114 · Cited by 4
Wang, H., Lakshmana, M. K., & Fields, G. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31218 · Cited by 4
Ono, M., Ito, T., Yamaki, S., Hori, Y., Zhou, Q., Zhao, X., Muramoto, S., Yamamoto, R., Furuyama, T., Sakata‐Haga, H., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28821 · Cited by 3
The Dynamic Role of the Golgi Apparatus in Neuronal Function and Alzheimer’s Disease
Fourrière, L., & Gleeson, P. A. (2026) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-032-16833-7_18 · Cited by 2
Self-citationTight control of the APP-Mint1 interaction in regulating amyloid production
Henry, S. M., Kistler, S. A., Lagani, G. D., Bartling, C. R. O., Özcelik, D., Sereikaité, V., Strømgaard, K., Beffert, U., & Ho, A. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148496 · Cited by 2
Lifelong heat exposure as a potential contributor to Alzheimer's disease resilience
Canet, G., Lucey, B. P., Blessing, E. M., & Planel, E. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261433226 · Cited by 2
BT2 as a novel therapeutic compound for Alzheimer’s disease
Mullins, C. A. (2023) · ThinkTech (Texas Tech University)
Sadagopan, S. (2026) · ScholarSpace (University of Hawaii at Manoa)
Swedish APP follows distinct neuronal trafficking itineraries that underlie its increased β-cleavagePreprint
Plowinske, C. R., Tedesco, S., Nabb, A. T., Quinones, G. B., & Bentley, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.22.746059
Golgi dysfunction in Alzheimer disease: from human multiomic signatures to therapeutic targets
Song, J., Lee, S., & Mook‐Jung, I. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01851-8
Inhibition of glycan sialylation reduces amyloid-β secretion via suppression of amyloid-β exocytosis
Urano, Y., Maeda, W., & Noguchi, N. (2026) · Biochimie · doi:10.1016/j.biochi.2026.10.016
Metadata
- Authors
- Fourriere, L., & Gleeson, P. A.
- Affiliations
- The Department of Biochemistry and Pharmacology and Bio21 Molecular Science and Biotechnology Institute The University of Melbourne Melbourne Victoria Australia
- The University of Melbourne (AU)
- Corresponding author
- Gleeson, Paul A.
- ORCID
- Gleeson, Paul A.
- Venue
- Traffic
- Publisher
- Wiley
- Published
- 2021-07-11
- Volume
- 22
- Issue
- 9
- Pages
- 319-327
- ISSN
- 1398-9219 (ISSN-L)
- 1600-0854
- OpenAlex
- W3174245108
- Semantic Scholar
- 33aba895f5fa44322c2407881368ed5a933bebd4
- Cited by
- 25
- References
- 111
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 5 · 2023: 4 · 2022: 6
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Traffic (publishedVersion)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- National Health and Medical Research Council (APP1163862)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- amyloid-beta production, APP processing, Golgi apparatus, BACE1, trans-Golgi network, membrane trafficking, Alzheimer's disease, endosomes, cholesterol metabolism, Golgi morphology
- MeSH terms
- Alzheimer Disease, Humans, Neurons, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Protein Transport, Amyloid Precursor Protein Secretases, Secretory Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.